Volume 53, Issue 12

Search all Cancer Immunology, Immunotherapy articles

December 2004

Filter by

Volume:

Sort by

Date published:

New to old Old to new

11 articles in this issue

Targeting the immune system: novel therapeutic approaches in squamous cell carcinoma of the head and neck
Thomas K. Hoffmann
Henning Bier
Theresa L. Whiteside
Review 17 April 2004 Pages: 1055 - 1067
Tumor-specific immunity in MUC1.Tg mice induced by immunization with peptide vaccines from the cytoplasmic tail of CD227 (MUC1)
Karl G. Kohlgraf
Andrew J. Gawron
Michael A. Hollingsworth
Original Article 25 June 2004 Pages: 1068 - 1084
Comparison of PSA-specific CD8⁺ CTL responses and antitumor immunity generated by plasmid DNA vaccines encoding PSA-HSP chimeric proteins
Maxim Pavlenko
Anna-Karin Roos
Pavel Pisa
Original Article 04 June 2004 Pages: 1085 - 1092
Monocyte-derived dendritic cells that capture dead tumor cells secrete IL-12 and TNF-α through IL-12/TNF-α/NF-κB autocrine loop
Hideya Onishi
Hideo Kuroki
Takashi Morisaki
Original Article 18 June 2004 Pages: 1093 - 1100
Cocultures of metastatic and host immune cells: selective effects of NAMI-A for tumor cells
Marina Bacac
Marta Vadori
Sabrina Pacor
Original Article 25 June 2004 Pages: 1101 - 1110
Dendritic cell–tumor cell hybrid vaccination for metastatic cancer
Jose Alexandre M. Barbuto
Luis F. C. Ensina
Antonio C. Buzaid
Original Article 04 June 2004 Pages: 1111 - 1118
Analysis of the autoantibody repertoire in Burkitt’s lymphoma patients: frequent response against the transcription factor ATF-2
Christian Kersten
Jan Delabie
Alexander Fosså
Original Article 04 June 2004 Pages: 1119 - 1126
Modulation of monocyte–tumour cell interactions by Mycobacterium vaccae
Jarosław Baran
Monika Baj-Krzyworzeka
Marek Zembala
Original Article 30 June 2004 Pages: 1127 - 1134
CD4⁺ T cells kill Id⁺ B-lymphoma cells: FasLigand-Fas interaction is dominant in vitro but is redundant in vivo
Katrin U. Lundin
Valentina Screpanti
Bjarne Bogen
Original Article 31 August 2004 Pages: 1135 - 1145
Evidence for immune defects in breast and lung cancer patients
Iuliana Caras
A. Grigorescu
Aurora Salageanu
Original Article 04 June 2004 Pages: 1146 - 1152
Cancer Immunotherapy 2004: Mainz, Germany, 6–7 May 2004
C. M. Britten
L. Mueller
G. Pawelec
Meeting Report 31 August 2004 Pages: 1153 - 1158

Volume 53, Issue 12

Targeting the immune system: novel therapeutic approaches in squamous cell carcinoma of the head and neck

Tumor-specific immunity in MUC1.Tg mice induced by immunization with peptide vaccines from the cytoplasmic tail of CD227 (MUC1)

Comparison of PSA-specific CD8⁺ CTL responses and antitumor immunity generated by plasmid DNA vaccines encoding PSA-HSP chimeric proteins

Monocyte-derived dendritic cells that capture dead tumor cells secrete IL-12 and TNF-α through IL-12/TNF-α/NF-κB autocrine loop

Cocultures of metastatic and host immune cells: selective effects of NAMI-A for tumor cells

Dendritic cell–tumor cell hybrid vaccination for metastatic cancer

Analysis of the autoantibody repertoire in Burkitt’s lymphoma patients: frequent response against the transcription factor ATF-2

Modulation of monocyte–tumour cell interactions by Mycobacterium vaccae

CD4⁺ T cells kill Id⁺ B-lymphoma cells: FasLigand-Fas interaction is dominant in vitro but is redundant in vivo

Evidence for immune defects in breast and lung cancer patients

Cancer Immunotherapy 2004: Mainz, Germany, 6–7 May 2004

Navigation